A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
Title:
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
Author:
Ngoi, Natalie YL Heong, Valerie Ow, Samuel Chay, Wen Yee Kim, Hee Seung Choi, Chel Hun Goss, Geraldine Goh, Jeffrey C Tai, Bee Choo Lim, Diana GZ Kaliaperumal, Nivashini Au, Veonice B Connolly, John E Kim, Jae-Weon Friedlander, Michael Kim, Kidong Tan, David SP
Appeared in:
International journal of gynecological cancer
Paging:
Volume 30 () nr. 8 pages 1239-1242
Year:
2020
Contents:
Publisher:
IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.